Literature DB >> 17322424

Efficient transgenic rat production by a lentiviral vector.

Mieczyslaw Michalkiewicz1, Teresa Michalkiewicz, Aron M Geurts, Richard J Roman, Glenn R Slocum, Oded Singer, Dorothee Weihrauch, Andrew S Greene, Mary Kaldunski, Inder M Verma, Howard J Jacob, Allen W Cowley.   

Abstract

A lentiviral construct for an enhanced green fluorescent protein (eGFP) driven by a chicken beta-actin promoter, cytomegalovirus enhancer, and intronic sequences from rabbit beta-globin (CAG) was used to produce transgenic lines of rats for evaluation of the usefulness of this approach in gene function studies. Fertilized eggs were collected from inbred Dahl S and outbred Sprague-Dawley rats, and approximately 100 pl of concentrated virus were microinjected into the perivitrelline space of one-cell embryos. Of 121 embryos injected, 60 pups (49.6%) were born. Transgenic rates averaged 22% in Dahl S and 14% in Sprague-Dawley rats. Copy number ranged from one to four in the founders, and the inheritance of the transgene in a subsequent F(1) population was 48.2%. The small number of insertion sites enabled us to derive inbred transgenic lines with a single copy of the transgene within one generation. Sequencing of each transgene insertion site revealed that they inserted as single copies with a preference for the introns of genes. The CAG promoter drove high levels of eGFP expression in brain, kidney, heart, and vasculature, making it very suitable for exploring the cardiovascular function of newly discovered genes. The pattern of eGFP expression was similar across five different F(1) transgenic lines, indicating that the expression of the transgene was independent of its chromosomal position. Thus lentiviral transgenesis provides a powerful tool for the production of transgenic inbred rats and will enhance the usefulness of this species in gene discovery and target validation studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322424     DOI: 10.1152/ajpheart.00060.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  22 in total

1.  Gene therapy to the kidney using viral vectors.

Authors:  Talha Akbulut; Frank Park
Journal:  Paidiatrike       Date:  2008

2.  New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy.

Authors:  S Remy; L Tesson; C Usal; S Menoret; V Bonnamain; V Nerriere-Daguin; J Rossignol; C Boyer; T H Nguyen; P Naveilhan; L Lescaudron; I Anegon
Journal:  Transgenic Res       Date:  2010-01-22       Impact factor: 2.788

3.  Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons.

Authors:  Zoltán Ivics; Lajos Mátés; Tien Yin Yau; Vladimír Landa; Vaclav Zidek; Sanum Bashir; Orsolya I Hoffmann; László Hiripi; Wiebke Garrels; Wilfried A Kues; Zsuzsanna Bösze; Aron Geurts; Michal Pravenec; Thomas Rülicke; Zsuzsanna Izsvák
Journal:  Nat Protoc       Date:  2014-03-13       Impact factor: 13.491

4.  Efficient mammalian germline transgenesis by cis-enhanced Sleeping Beauty transposition.

Authors:  Daniel F Carlson; Aron M Geurts; John R Garbe; Chang-Won Park; Artur Rangel-Filho; Scott M O'Grady; Howard J Jacob; Clifford J Steer; David A Largaespada; Scott C Fahrenkrug
Journal:  Transgenic Res       Date:  2010-03-30       Impact factor: 2.788

Review 5.  2015 Guidelines for Establishing Genetically Modified Rat Models for Cardiovascular Research.

Authors:  Michael J Flister; Jeremy W Prokop; Jozef Lazar; Mary Shimoyama; Melinda Dwinell; Aron Geurts
Journal:  J Cardiovasc Transl Res       Date:  2015-04-29       Impact factor: 4.132

Review 6.  Applications of lentiviral vectors for shRNA delivery and transgenesis.

Authors:  Oded Singer; Inder M Verma
Journal:  Curr Gene Ther       Date:  2008-12       Impact factor: 4.391

7.  Identification of cell surface markers to differentiate rat endothelial and fibroblast cells using lectin arrays and LC-ESI-MS/MS.

Authors:  Ji Eun Lee; Shama P Mirza; Daniela N Didier; Mark Scalf; Michael Olivier; Andrew S Greene; Lloyd M Smith
Journal:  Anal Chem       Date:  2008-09-27       Impact factor: 6.986

8.  Generation and characterization of a Tet-On (rtTA-M2) transgenic rat.

Authors:  Yi Sheng; Chih-Cheng Lin; Junming Yue; Meena Sukhwani; Jennifer J Shuttleworth; Tianjiao Chu; Kyle E Orwig
Journal:  BMC Dev Biol       Date:  2010-02-16       Impact factor: 1.978

9.  Knockout rats via embryo microinjection of zinc-finger nucleases.

Authors:  Aron M Geurts; Gregory J Cost; Yevgeniy Freyvert; Bryan Zeitler; Jeffrey C Miller; Vivian M Choi; Shirin S Jenkins; Adam Wood; Xiaoxia Cui; Xiangdong Meng; Anna Vincent; Stephen Lam; Mieczyslaw Michalkiewicz; Rebecca Schilling; Jamie Foeckler; Shawn Kalloway; Hartmut Weiler; Séverine Ménoret; Ignacio Anegon; Gregory D Davis; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Howard J Jacob; Roland Buelow
Journal:  Science       Date:  2009-07-24       Impact factor: 47.728

10.  Variegation and silencing in a lentiviral-based murine transgenic model.

Authors:  Delphine Baup; Laurent Fraga; Eileen Pernot; Annette Van Acker; Anne-Sophie Vanherck; Karine Breckpot; Kris Thielemans; Stéphane Schurmans; Muriel Moser; Oberdan Leo
Journal:  Transgenic Res       Date:  2009-08-23       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.